Inventor · disambiguated record
Michael Graziano
Also filed as: GRAZIANO MICHAEL P
8 granted patents·10 pending applications·55 citations·filing 1997–2011
86Inventor score
Top patents by PatentIndex Score
18 records- 0184US6632933B2Use of azetidinone compoundsSCHERING CORP·Filed 2001·Granted Oct 14, 2003·18 cites·3 claims
- 0284US6593078B1Use of azetidinone compoundsSCHERING CORP·Filed 2000·Granted Jul 15, 2003·11 cites·6 claims
- 0379US7442712B2Constrained himbacine analogs as thrombin receptor antagonistsSCHERING CORP·Filed 2005·Granted Oct 28, 2008·6 cites·15 claims
- 0467US7723020B2Use of azetidinone compoundsSCHERING CORP·Filed 2006·Granted May 25, 2010·0 cites·6 claims
- 0567US7144696B2Use of azetidinone compoundsSCHERING CORP·Filed 2005·Granted Dec 5, 2006·1 cites·4 claims
- 0662US7135556B2NPC1L1 (NPC3) and methods of use thereofSCHERING CORP·Filed 2003·Granted Nov 14, 2006·5 cites·13 claims
- 0758US5889167ASynthetic glucagon binding proteinsMERCK & CO INC·Filed 1997·Granted Mar 30, 1999·13 cites·5 claims
- 0857US6933107B2Use of azetidinone compoundsSCHERING CORP·Filed 2003·Granted Aug 23, 2005·1 cites·11 claims
- 0952US2007203193A1Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonistSCHERING CORP·Filed 2007·Application pending·0 cites
- 1052US2007021592A1NPC1L1 (NPC3) and methods of use thereofSCHERING CORP·Filed 2006·Application pending·0 cites
- 1150US2004132058A1NPC1L1 (NPC3) and methods of use thereofSCHERING CORP·Filed 2003·Application pending·0 cites
- 1249US2004137467A1NPC1L1 (NPC3) and methods of use thereofSCHERING CORP·Filed 2003·Application pending·0 cites
- 1348US2004097482A1Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indicationsSCHERING CORP·Filed 2003·Application pending·0 cites
- 1446US2004093629A1NPC1L1 (NPC3) and methods of use thereofSCHERING CORP·Filed 2003·Application pending·0 cites
- 1546US2005096307A1Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditionsSCHERING CORP·Filed 2004·Application pending·0 cites
- 1646US2012079616A1Npc1l1 (npc3) and methods of use thereofALTMANN SCOTT W·Filed 2011·Application pending·0 cites
- 1742US2007142369A1Combination of an H3 antagonist/inverse agonist and an appetite suppressantVAN HEEK MARGARET·Filed 2006·Application pending·0 cites
- 1840US2004192753A1Methods of use of thrombin receptor antagonistsFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →